Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis prediction. Furthermore, it might represent certain therapeutic interventions through some combinations of biomarkers. Here, we review on our current understanding of HCC biomarkers.
No takes yet. Share an insight, caveat, or question.
Lou et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: